RU2011129530A - METHOD FOR TREATING HEMORRHAGIC SHOCK I, II, AND III DEGREE OF SEVERITY - Google Patents
METHOD FOR TREATING HEMORRHAGIC SHOCK I, II, AND III DEGREE OF SEVERITY Download PDFInfo
- Publication number
- RU2011129530A RU2011129530A RU2011129530/15A RU2011129530A RU2011129530A RU 2011129530 A RU2011129530 A RU 2011129530A RU 2011129530/15 A RU2011129530/15 A RU 2011129530/15A RU 2011129530 A RU2011129530 A RU 2011129530A RU 2011129530 A RU2011129530 A RU 2011129530A
- Authority
- RU
- Russia
- Prior art keywords
- severity
- hemorrhagic shock
- volume
- iii
- per day
- Prior art date
Links
Landscapes
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Abstract
Способ лечения геморрагического шока I, II и III степени тяжести с помощью коллоидных и кристаллоидных растворов, отличающийся тем, что включает в программу инфузионной терапии сбалансированный кристаллоидный раствор стерофундин изотонического в объеме 3000 мл в сутки при геморрагическом шоке I степени тяжести, в объеме 1200 мл в сутки при геморрагическом шоке II и III степени тяжести и 4%-ный коллоидный раствор модифицированного желатина в объеме 1000 мл при геморрагическом шоке I степени тяжести, в объеме 2500 мл в сутки при геморрагическом шоке II степени тяжести, в объеме 3500 мл в сутки мл при геморрагическом шоке III степени тяжести.A method for the treatment of hemorrhagic shock of I, II and III severity with the help of colloidal and crystalloid solutions, characterized in that it includes a balanced crystalloid solution of sterofundin isotonic steroid in a volume of 3000 ml per day with hemorrhagic shock of I severity, in a volume of 1200 ml day with hemorrhagic shock of II and III severity and a 4% colloidal solution of modified gelatin in a volume of 1000 ml with hemorrhagic shock of I severity, in a volume of 2500 ml per day with hemorrhagic shock II fines of severity, in a volume of 3500 ml per day ml with hemorrhagic shock of III severity.
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011129530/15A RU2482840C2 (en) | 2011-07-15 | 2011-07-15 | Method of treating hemorrhagic shock of i, ii and iii degree of severity |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
RU2011129530/15A RU2482840C2 (en) | 2011-07-15 | 2011-07-15 | Method of treating hemorrhagic shock of i, ii and iii degree of severity |
Publications (2)
Publication Number | Publication Date |
---|---|
RU2011129530A true RU2011129530A (en) | 2013-01-20 |
RU2482840C2 RU2482840C2 (en) | 2013-05-27 |
Family
ID=48792090
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU2011129530/15A RU2482840C2 (en) | 2011-07-15 | 2011-07-15 | Method of treating hemorrhagic shock of i, ii and iii degree of severity |
Country Status (1)
Country | Link |
---|---|
RU (1) | RU2482840C2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
RU2677333C1 (en) * | 2018-03-14 | 2019-01-16 | федеральное государственное бюджетное образовательное учреждение высшего образования "Омский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО ОмГМУ Минздрава России) | Method of treating traumatic shock of iii severity degree |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2008135963A2 (en) * | 2007-05-02 | 2008-11-13 | Hemogem Inc. | Fibrinogen for treatment of bleeding in trauma and platelet disorders |
RU2387452C1 (en) * | 2008-09-01 | 2010-04-27 | Федеральное государственное учреждение Новосибирский научно-исследовательский институт травматологии и ортопедии Федерального агентства по высокотехнологичной медицинской помощи (ФГУ ННИИТО Росмедтехнологий) | Method of infusion medication of spinal surgery in children |
-
2011
- 2011-07-15 RU RU2011129530/15A patent/RU2482840C2/en not_active IP Right Cessation
Also Published As
Publication number | Publication date |
---|---|
RU2482840C2 (en) | 2013-05-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CY1118125T1 (en) | IBA suspensions for US disease treatment | |
UA114902C2 (en) | Anti-phf-tau antibodies and their uses | |
EA201491151A1 (en) | METALLIC ENZYME INHIBITING COMPOUNDS | |
EA201791393A3 (en) | ANTIBODIES TO ERBB3 AND THEIR APPLICATION | |
EA201400333A1 (en) | BENZONITRIL DERIVATIVES AS KINAZ INHIBITORS | |
EA201591286A1 (en) | QUANTITATIVE ESTIMATION OF CEP EFFICIENCY OF MATRIX RNA | |
CY1119173T1 (en) | New Molecular Suspension JNK | |
EA201400875A1 (en) | ANTIBODIES TO CD47 AND METHODS OF THEIR APPLICATION | |
EA201490029A1 (en) | METALLIC ENZYME INHIBITING COMPOUNDS | |
EA201490088A1 (en) | METALLIC ENZYME INHIBITING COMPOUNDS | |
EA201490036A1 (en) | METALLIC ENZYME INHIBITING COMPOUNDS | |
EA201491215A1 (en) | NON-TILED ANTI-INFLAMMATORY POLYPEPTIDES | |
EA201492184A1 (en) | METHODS OF TREATMENT OF METABOLIC SYNDROME BY MODULATING PROTEIN HEAT SHOCK (HSP) 90-BETA | |
EA201300819A1 (en) | ANTIBODY MOLECULES THAT ASSOCIATE WITH IL-17A AND IL-17F | |
BR112013032215A2 (en) | Method and System for Processing Financial Account Balance Queries | |
PH12014501164A1 (en) | Anti-cd98 antibodies and methods of use thereof | |
WO2014133855A8 (en) | Tuberculosis biomarkers and uses thereof | |
EA201391389A1 (en) | CRYSTALS OF ANTIBODIES AGAINST SKLEROSTIN AND COMPOSITIONS ON THEIR BASIS | |
EA201390704A1 (en) | METALLIC ENZYME INHIBITING COMPOUNDS | |
AR091722A1 (en) | CRYSTAL FORM OF AN INDOLINONE DERIVATIVE AND ITS USE | |
EA201490767A1 (en) | CLUSTER GENES BIOSYNTHESIS OF GRILLYLIMICINE AND METHYLRISYLIMICITY | |
RU2011129530A (en) | METHOD FOR TREATING HEMORRHAGIC SHOCK I, II, AND III DEGREE OF SEVERITY | |
EA201391335A1 (en) | SUBSTITUTED DIPHENYL DERIVATIVES | |
EA201491455A1 (en) | EFFECTORS β-ARRESTINA, COMPOSITIONS, THEIR CONTAINING, AND METHODS OF THEIR USE | |
EA201391459A1 (en) | TREATMENT MODES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20140716 |